
Image Credit: Scientific Frontline
Scientific Frontline: Extended "At a Glance" Summary: CD47-Mediated Glioblastoma Progression
The Core Concept: Researchers have discovered that the protein CD47 plays a direct, internal role in driving the growth, movement, and invasion of glioblastoma cells into healthy brain tissue, operating independently of its previously established function in immune evasion.
Key Distinction/Mechanism: While CD47 was previously recognized solely as an extracellular "don't eat me" signal that helps cancer cells hide from the immune system, its newly identified mechanism is intracellular. CD47 sequesters a protein called ITCH, preventing it from breaking down another key protein, ROBO2. This shielding allows ROBO2 to accumulate and actively drive tumor progression and invasion.
Major Frameworks/Components:
- CD47: A protein found in high abundance at the invasive edges of glioblastoma tumors, directly correlating with poorer patient survival outcomes.
- ROBO2: A downstream partner protein shielded by CD47 that facilitates cancer cell proliferation, migration, and invasion.
- ITCH: A protein responsible for tagging ROBO2 for cellular degradation, whose function is inhibited when sequestered by CD47.
- CD47-ITCH-ROBO2 Pathway: The newly identified molecular chain of events acting as a central regulator of glioblastoma biology.
.jpg)
.jpg)



.jpg)

.jpg)





.jpg)

.jpg)


